Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Half-life and vitreous clearance of trifluorothymidine after intravitreal injection in the rabbit eye.

Pang MP, Branchflower RV, Chang AT, Peyman GA, Blatt H, Minatoya HK.

Can J Ophthalmol. 1992 Feb;27(1):6-9.

PMID:
1555136
2.
3.
5.
6.

Eye injuries from exploding car batteries.

Minatoya HK.

Arch Ophthalmol. 1978 Mar;96(3):477-81.

PMID:
564686
7.

Esters of N-tert-butylarterenol. Long-acting new bronchodilators with reduced cardiac effects.

Tullar BF, Minatoya H, Lorenz RR.

J Med Chem. 1976 Jun;19(6):834-8.

PMID:
950653
8.

Comparison of animal models for predicting bronchodilator efficacy in man.

Spilker B, Minatoya H, McKeon WB Jr.

Arch Int Pharmacodyn Ther. 1975 Oct;217(2):218-35.

PMID:
1190917
9.

The role of bronchoconstrictors in evaluating smooth muscle relaxant activity.

Spilker B, Minatoya H.

Arch Int Pharmacodyn Ther. 1975 Oct;217(2):201-17.

PMID:
242289
10.

Cardiovascular effects and blood concentrations of ajmaline and its 17-monochloroacetate ester in cats.

Spilker B, Shargel L, Koss RF, Minatoya H.

Arch Int Pharmacodyn Ther. 1975 Jul;216(1):63-78.

PMID:
1164107
11.

Lack of cardiac or bronchodilator tachyphylaxis to isoprenaline in the dog.

Minatoya H, Spilker BA.

Br J Pharmacol. 1975 Mar;53(3):333-40.

12.

Fluorescein angiography of the bulbar conjunctiva in sickle cell disease.

Minatoya H, Acacio I, Goldberg M.

Ann Ophthalmol. 1973 Sep;5(9):980-92. No abstract available.

PMID:
4743859
13.

A survey on macrophotography of the eye.

Minatoya HK.

Surv Ophthalmol. 1972 Sep-Oct;17(2):100-5. No abstract available.

PMID:
4679637
14.

Absorption and elimination profile of isoproterenol. 3. The metabolic fate of dl-isoproterenol-7-3H in the dog.

Conway WD, Minatoya H, Lands AM, Shekosky JM.

J Pharm Sci. 1968 Jul;57(7):1135-41. No abstract available.

PMID:
5662050
15.

Absorption and elimination profile of isoproterenol. II. Parenteral, oral, and rectal administration to unanesthetized dogs.

Portmann GA, Minatoya H, Lands AM.

J Pharm Sci. 1965 Jul;54(7):973-8. No abstract available.

PMID:
5862534
16.

Absorption and elimination profile of isoproterenol. I. Anesthetized dogs.

Minatoya H, Lands AM, Portmann GA.

J Pharm Sci. 1965 Jul;54(7):968-72. No abstract available.

PMID:
5862533
17.

HYPOTENSIVE ACTIVITY OF NORTROPINE AND NORPSEUDOTROPINE SUBSTITUTED PHENOTHIAZINES IN HYPERTENSIVE AND NORMOTENSIVE ANIMALS.

MINATOYA H.

Arch Int Pharmacodyn Ther. 1963 Sep 1;145:97-108. No abstract available.

PMID:
14077698
18.

Comparison of parenterally administered calcium kinate gluconate with calcium gluconate and calcium chloride.

COULSTON F, HULME NA, MIELENS ZE, MINATOYA H.

Toxicol Appl Pharmacol. 1962 Jul;4:492-503. No abstract available.

PMID:
13881713
20.

Effects of mercurial diuretics on urine volume and chloride excretion in the rat with additional observations on toxicity.

MINATOYA H, HOPPE JO.

J Am Pharm Assoc Am Pharm Assoc. 1951 Aug;40(8):394-8. No abstract available.

PMID:
14861098
21.

Further observations on the prophylaxis of experimental renal hypertension with renal extracts.

WAKERLIN GE, MINATOYA H, et al.

Fed Proc. 1947;6(1 Pt 2):220. No abstract available.

PMID:
20342907
22.

Prophylaxis of experimental renal hypertension with renal extracts.

WAKERLIN GE, MINATOYA H, et al.

Proc Annu Meet Cent Soc Clin Res U S. 1946 Nov 1-2;19:38. No abstract available.

PMID:
20248542
23.

The effect of unilateral nephrectomy on the development and maintenance of experimental renal hypertension.

WAKERLIN GE, LEFCO T, MINATOYA H.

Fed Proc. 1946;5(1 Pt 2):107. No abstract available.

PMID:
21066519
24.

Additional observations on the prophylaxis of experimental renal hypertension with renal extracts.

WAKERLIN GE, MINATOYA H, LEFCO T.

Fed Proc. 1946;5(1 Pt 2):107. No abstract available.

PMID:
21066518

Supplemental Content

Loading ...
Support Center